Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10(9):668–80. https://doi.org/10.1016/s2213-8587(22)00163-2.

Article  CAS  PubMed  Google Scholar 

Luo X, Cai WY, Wu XK. Prevalence, pattern and predictors for dyslipidemia of Chinese women with polycystic ovary syndrome. Front Cardiovasc Med. 2021;8:790454. https://doi.org/10.3389/fcvm.2021.790454.

Article  PubMed  PubMed Central  Google Scholar 

Wild RA, Rizzo M, Clifton S, Carmina E. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011;95(3):1073–9. https://doi.org/10.1016/j.fertnstert.2010.12.027. .e1-11.

Article  CAS  PubMed  Google Scholar 

Haoula Z, Ravipati S, Stekel DJ, Ortori CA, Hodgman C, Daykin C, et al. Lipidomic analysis of plasma samples from women with polycystic ovary syndrome. Metabolomics. 2015;11(3):657–66. https://doi.org/10.1007/s11306-014-0726-y.

Article  CAS  PubMed  Google Scholar 

Mousa A, Huynh K, Ellery SJ, Strauss BJ, Joham AE, de Courten B, et al. Novel lipidomic signature associated with metabolic risk in women with and without polycystic ovary syndrome. J Clin Endocrinol Metab. 2022;107(5):e1987–99. https://doi.org/10.1210/clinem/dgab931.

Article  PubMed  Google Scholar 

Niu Z, Lin N, Gu R, Sun Y, Feng Y. Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization. J Clin Endocrinol Metab. 2014;99(11):E2269–76. https://doi.org/10.1210/jc.2013-3942.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang XJ, Huang LL, Su H, Chen YX, Huang J, He C, et al. Characterizing plasma phospholipid fatty acid profiles of polycystic ovary syndrome patients with and without insulin resistance using GC-MS and chemometrics approach. J Pharm Biomed Anal. 2014;95:85–92. https://doi.org/10.1016/j.jpba.2014.02.014.

Article  CAS  PubMed  Google Scholar 

Tian Y, Zhang J, Li M, Shang J, Bai X, Zhang H, et al. Serum fatty acid profiles associated with metabolic risk in women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023;14:1077590. https://doi.org/10.3389/fendo.2023.1077590.

Article  PubMed  Google Scholar 

Niu Z, Ye Y, Xia L, Feng Y, Zhang A. Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization. Cytokine. 2017;91:180–6. https://doi.org/10.1016/j.cyto.2016.12.020.

Article  CAS  PubMed  Google Scholar 

Liu L, Yin TL, Chen Y, Li Y, Yin L, Ding J, et al. Follicular dynamics of glycerophospholipid and sphingolipid metabolisms in polycystic ovary syndrome patients. J Steroid Biochem Mol Biol. 2019;185:142–9. https://doi.org/10.1016/j.jsbmb.2018.08.008.

Article  CAS  PubMed  Google Scholar 

Feng Y, Qi J, Xue X, Li X, Liao Y, Sun Y, et al. Follicular free fatty acid metabolic signatures and their effects on oocyte competence in non-obese PCOS patients. Reproduction. 2022;164(1):1–8. https://doi.org/10.1530/rep-22-0023.

Article  CAS  PubMed  Google Scholar 

Lai Y, Ye Z, Mu L, Zhang Y, Long X, Zhang C, et al. Elevated levels of follicular fatty acids induce ovarian inflammation via ERK1/2 and inflammasome activation in PCOS. J Clin Endocrinol Metab. 2022;107(8):2307–17. https://doi.org/10.1210/clinem/dgac281.

Article  PubMed  Google Scholar 

Group REA-SPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. https://doi.org/10.1016/j.fertnstert.2003.10.004.

Article  Google Scholar 

Zarezadeh R, Nouri M, Hamdi K, Shaaker M, Mehdizadeh A, Darabi M. Fatty acids of follicular fluid phospholipids and triglycerides display distinct association with IVF outcomes. Reprod Biomed Online. 2021;42(2):301–9. https://doi.org/10.1016/j.rbmo.2020.09.024.

Article  CAS  PubMed  Google Scholar 

Emami N, Alizadeh A, Moini A, Yaghmaei P, Shahhosseini M. Differences in fatty acid profiles and desaturation indices of abdominal subcutaneous adipose tissue between pregnant women with and without PCOS. Adipocyte. 2020;9(1):16–23. https://doi.org/10.1080/21623945.2019.1710021.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang CH, Liu XY, Wang J. Essential role of granulosa cell glucose and lipid metabolism on oocytes and the potential metabolic imbalance in polycystic ovary syndrome. Int J Mol Sci. 2023. https://doi.org/10.3390/ijms242216247.

Article  PubMed  PubMed Central  Google Scholar 

Liu J, Li J, Wu X, Zhang M, Yan G, Sun H, et al. High levels of fatty acid-binding protein 5 excessively enhances fatty acid synthesis and proliferation of granulosa cells in polycystic ovary syndrome. J Ovarian Res. 2024;17(1):44. https://doi.org/10.1186/s13048-024-01368-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hennet ML, Combelles CM. The antral follicle: a microenvironment for oocyte differentiation. Int J Dev Biol. 2012;56(10–12):819–31. https://doi.org/10.1387/ijdb.120133cc.

Article  CAS  PubMed  Google Scholar 

Valckx SD, Arias-Alvarez M, De Pauw I, Fievez V, Vlaeminck B, Fransen E, et al. Fatty acid composition of the follicular fluid of normal weight, overweight and obese women undergoing assisted reproductive treatment: a descriptive cross-sectional study. Reprod Biol Endocrinol. 2014;12:13. https://doi.org/10.1186/1477-7827-12-13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dunning KR, Russell DL, Robker RL. Lipids and oocyte developmental competence: the role of fatty acids and β-oxidation. Reproduction. 2014;148(1):R15–27. https://doi.org/10.1530/rep-13-0251.

Article  CAS  PubMed  Google Scholar 

Liu Y, Tilleman K, Vlaeminck B, Gervais R, Chouinard PY, De Sutter P, et al. Composition and distribution of fatty acids in various lipid fractions in serum and follicular fluid of women undergoing assisted reproductive technology. PLoS ONE. 2023;18(6):e0286946. https://doi.org/10.1371/journal.pone.0286946.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moreira MV, Vale-Fernandes E, Albergaria IC, Alves MG, Monteiro MP. Follicular fluid composition and reproductive outcomes of women with polycystic ovary syndrome undergoing in vitro fertilization: a systematic review. Rev Endocr Metab Disord. 2023;24(6):1045–73. https://doi.org/10.1007/s11154-023-09819-z.

Article  PubMed  PubMed Central  Google Scholar 

Xu Y, Zhou Z, Zhang G, Yang Z, Shi Y, Jiang Z, et al. Metabolome implies increased fatty acid utilization and histone methylation in the follicles from hyperandrogenic PCOS women. J Nutr Biochem. 2024;125:109548. https://doi.org/10.1016/j.jnutbio.2023.109548.

Article  CAS  PubMed  Google Scholar 

Naigaonkar A, Dadachanji R, Hinduja I, Mukherjee S. Altered redox status May contribute to aberrant folliculogenesis and poor reproductive outcomes in women with polycystic ovary syndrome. J Assist Reprod Genet. 2021;38(10):2609–23. https://doi.org/10.1007/s10815-021-02241-x.

Article  PubMed  PubMed Central  Google Scholar 

Nafiye Y, Sevtap K, Muammer D, Emre O, Senol K, Leyla M. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome. Fertil Steril. 2010;93(6):1864–9. https://doi.org/10.1016/j.fertnstert.2008.12.024.

Article  CAS  PubMed  Google Scholar 

Emanuel RHK, Roberts J, Docherty PD, Lunt H, Campbell RE, Möller K. A review of the hormones involved in the endocrine dysfunctions of polycystic ovary syndrome and their interactions. Front Endocrinol (Lausanne). 2022;13:1017468. https://doi.org/10.3389/fendo.2022.1017468.

Article  PubMed  Google Scholar 

Dai M, Hong L, Yin T, Liu S. Disturbed follicular microenvironment in polycystic ovary syndrome: relationship to oocyte quality and infertility. Endocrinology. 2024. https://doi.org/10.1210/endocr/bqae023.

Article  PubMed